Investment analysts at HC Wainwright boosted their FY2027 EPS estimates for shares of Oncolytics Biotech in a research report ...

HC Wainwright issued their Q1 2025 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, ...

H.C. Wainwright lowered the firm’s price target on Vigil Neuroscience (VIGL) to $14 from $17 and keeps a Buy rating on the shares ahead of ...

H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on IN8bio (INAB) to $6 from $8 and keeps a Buy rating on the ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Quantum computing continues to advance rapidly, which has been helping businesses get new opportunities related to security, ...

Discover how Bit Digital's Q4 2024 results showcase a 141% revenue increase, a strategic shift to HPC with WhiteFiber, and a strong pipeline for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

U.S. stocks were higher, with the Dow Jones index gaining around 1% on Friday. Shares of Semtech Corporation SMTC rose ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

Welcome to the Aemetis fourth-quarter and year-end 2024 earnings review conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce ...